Meilong Wu
Overview
Explore the profile of Meilong Wu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
100
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wu M, Xiao Y, Wang Y, Deng L, Wang X, An T
Pathology
. 2024 Dec;
57(3):320-327.
PMID: 39668071
According to previous studies, vessels encapsulating tumour clusters (VETC) could promote metastasis of hepatocellular carcinoma (HCC) in a manner independent from epithelial-mesenchymal transition (EMT). However, the prognostic significance of VETC...
2.
Zhang Q, Zhang Y, Fu C, He X, Huang Z, Wu G, et al.
Cancer Res
. 2024 Nov;
85(3):515-534.
PMID: 39514400
Cleavage stimulation factor subunit 2 (CSTF2) is a fundamental factor in the regulation of 3'-end cleavage and alternative polyadenylation of pre-mRNAs. Previous work has identified a tumor-promoting role of CSTF2,...
3.
Zhang Q, Wei T, Jin W, Yan L, Shi L, Zhu S, et al.
J Hepatol
. 2024 Mar;
80(2):293-308.
PMID: 38450598
Background & Aims: The role of solute carrier family 25 member 15 (SLC25A15), a critical component of the urea cycle, in hepatocellular carcinoma (HCC) progression remains poorly understood. This study...
4.
An T, Wang Y, Liu L, Wang Y, Deng L, Wu M
Langenbecks Arch Surg
. 2024 Feb;
409(1):53.
PMID: 38316643
Purpose: Pringle maneuver (PM) is a double-edged sword in liver resection, which is beneficial in reducing blood loss but also causes ischemia-reperfusion injury which may stimulate the outgrowth of micrometastases....
5.
Zhang Q, Hu W, Xiong L, Wen J, Wei T, Yan L, et al.
Comput Struct Biotechnol J
. 2023 Aug;
21:3987-3998.
PMID: 37635767
Mining gene expression data is valuable for discovering novel biomarkers and therapeutic targets in hepatocellular carcinoma (HCC). Although emerging data mining tools are available for pan-cancer-related gene data analysis, few...
6.
Fan L, Wang Y, Wu M, Wu T, Deng L, Wang Y, et al.
BMC Geriatr
. 2023 Aug;
23(1):486.
PMID: 37568121
Background: For patients with choledocholithiasis, laparoscopic common bile duct exploration (LCBDE) is preferred over open surgery. Whether primary closure of the common bile duct (CBD) should be performed upon completion...
7.
Zhang Q, Wei T, Yan L, Zhu S, Jin W, Bai Y, et al.
Cancer Res
. 2023 Jun;
83(15):2496-2512.
PMID: 37326474
Significance: A micropeptide encoded by lncRNA AC115619 impedes formation of the m6A methylation complex to lower m6A levels and reduce the growth of hepatocellular carcinoma.
8.
Su Z, Li C, Fu H, Wang L, Wu M, Feng X
Math Biosci Eng
. 2023 Mar;
20(3):5316-5332.
PMID: 36896547
Liver cancer is a common cause of death from cancer in the population, with the 4th highest mortality rate from cancer worldwide. The high recurrence rate of hepatocellular carcinoma after...
9.
Wang L, Wu M, Zhu C, Li R, Bao S, Yang S, et al.
Front Oncol
. 2022 Nov;
12:1019009.
PMID: 36439437
Preoperative prediction of recurrence outcome in hepatocellular carcinoma (HCC) facilitates physicians' clinical decision-making. Preoperative imaging and related clinical baseline data of patients are valuable for evaluating prognosis. With the widespread...
10.
Wang L, Wu M, Li R, Xu X, Zhu C, Feng X
Cancers (Basel)
. 2022 Jun;
14(12).
PMID: 35740620
Microvascular invasion (MVI) in hepatocellular carcinoma (HCC) directly affects a patient's prognosis. The development of preoperative noninvasive diagnostic methods is significant for guiding optimal treatment plans. In this study, we...